| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | translation activator activity | 9.81e-08 | 15 | 60 | 4 | GO:0008494 | |
| GeneOntologyMolecularFunction | translation regulator activity, nucleic acid binding | 2.17e-05 | 112 | 60 | 5 | GO:0090079 | |
| GeneOntologyBiologicalProcess | female meiosis II | 9.02e-10 | 6 | 59 | 4 | GO:0007147 | |
| GeneOntologyBiologicalProcess | meiosis II | 9.02e-10 | 6 | 59 | 4 | GO:0007135 | |
| GeneOntologyBiologicalProcess | meiosis II cell cycle process | 9.02e-10 | 6 | 59 | 4 | GO:0061983 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 8.61e-07 | 26 | 59 | 4 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of translational initiation | 1.36e-06 | 29 | 59 | 4 | GO:0045948 | |
| GeneOntologyBiologicalProcess | 3'-UTR-mediated mRNA stabilization | 1.79e-06 | 31 | 59 | 4 | GO:0070935 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic cell cycle | 3.72e-06 | 37 | 59 | 4 | GO:0051446 | |
| GeneOntologyBiologicalProcess | regulation of meiotic nuclear division | 8.24e-06 | 45 | 59 | 4 | GO:0040020 | |
| GeneOntologyBiologicalProcess | oocyte maturation | 9.82e-06 | 47 | 59 | 4 | GO:0001556 | |
| GeneOntologyBiologicalProcess | female meiotic nuclear division | 1.48e-05 | 52 | 59 | 4 | GO:0007143 | |
| GeneOntologyBiologicalProcess | translational initiation | 3.78e-05 | 132 | 59 | 5 | GO:0006413 | |
| GeneOntologyBiologicalProcess | positive regulation of nuclear division | 6.31e-05 | 75 | 59 | 4 | GO:0051785 | |
| GeneOntologyBiologicalProcess | mRNA stabilization | 6.99e-05 | 77 | 59 | 4 | GO:0048255 | |
| GeneOntologyBiologicalProcess | regulation of meiotic cell cycle | 8.94e-05 | 82 | 59 | 4 | GO:0051445 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA catabolic process | 1.13e-04 | 87 | 59 | 4 | GO:1902373 | |
| GeneOntologyBiologicalProcess | RNA stabilization | 1.18e-04 | 88 | 59 | 4 | GO:0043489 | |
| GeneOntologyBiologicalProcess | regulation of translational initiation | 1.34e-04 | 91 | 59 | 4 | GO:0006446 | |
| GeneOntologyBiologicalProcess | oocyte development | 1.86e-04 | 99 | 59 | 4 | GO:0048599 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA catabolic process | 2.00e-04 | 101 | 59 | 4 | GO:1902369 | |
| GeneOntologyBiologicalProcess | oocyte differentiation | 2.16e-04 | 103 | 59 | 4 | GO:0009994 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.86e-04 | 9 | 59 | 2 | GO:0033133 | |
| GeneOntologyBiologicalProcess | negative regulation of mRNA metabolic process | 3.29e-04 | 115 | 59 | 4 | GO:1903312 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 3.57e-04 | 10 | 59 | 2 | GO:1903301 | |
| GeneOntologyBiologicalProcess | positive regulation of reproductive process | 3.63e-04 | 118 | 59 | 4 | GO:2000243 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 6.15e-04 | 13 | 59 | 2 | GO:0033131 | |
| GeneOntologyBiologicalProcess | developmental process involved in reproduction | SPATA31A3 AXL DAZ4 SPATA31A7 KDR DAZ1 DAZ3 DAZ2 SPATA31A5 ST14 VDR | 6.66e-04 | 1235 | 59 | 11 | GO:0003006 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 7.16e-04 | 14 | 59 | 2 | GO:1903299 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.24e-04 | 8 | 60 | 2 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.59e-04 | 10 | 60 | 2 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 7.21e-04 | 14 | 60 | 2 | GO:0005642 | |
| GeneOntologyCellularComponent | kinocilium | 7.21e-04 | 14 | 60 | 2 | GO:0060091 | |
| GeneOntologyCellularComponent | 9+2 non-motile cilium | 7.21e-04 | 14 | 60 | 2 | GO:0097732 | |
| GeneOntologyCellularComponent | cell surface | 1.15e-03 | 1111 | 60 | 10 | GO:0009986 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.20e-03 | 18 | 60 | 2 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.49e-03 | 20 | 60 | 2 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.64e-03 | 21 | 60 | 2 | GO:0106068 | |
| GeneOntologyCellularComponent | stereocilium tip | 1.80e-03 | 22 | 60 | 2 | GO:0032426 | |
| GeneOntologyCellularComponent | inclusion body | 2.21e-03 | 90 | 60 | 3 | GO:0016234 | |
| HumanPheno | Oligozoospermia | 1.80e-06 | 59 | 19 | 5 | HP:0000798 | |
| HumanPheno | Y-linked inheritance | 3.47e-05 | 18 | 19 | 3 | HP:0001450 | |
| MousePheno | absent ovarian follicles | 2.29e-05 | 51 | 46 | 4 | MP:0002777 | |
| MousePheno | abnormal ovarian follicle number | 5.03e-05 | 203 | 46 | 6 | MP:0008871 | |
| MousePheno | abnormal ovarian follicle morphology | 1.42e-04 | 245 | 46 | 6 | MP:0001131 | |
| MousePheno | lymphatic vessel hyperplasia | 1.58e-04 | 6 | 46 | 2 | MP:0004106 | |
| MousePheno | abnormal neural crest cell migration | 1.86e-04 | 34 | 46 | 3 | MP:0002950 | |
| MousePheno | abnormal seminiferous tubule morphology | 2.12e-04 | 377 | 46 | 7 | MP:0002216 | |
| MousePheno | small ovary | 2.84e-04 | 178 | 46 | 5 | MP:0001127 | |
| Domain | DUF4599 | 6.46e-06 | 12 | 59 | 3 | PF15371 | |
| Domain | DUF4599 | 6.46e-06 | 12 | 59 | 3 | IPR027970 | |
| Domain | ig | 2.95e-05 | 190 | 59 | 6 | PF00047 | |
| Domain | Immunoglobulin | 2.95e-05 | 190 | 59 | 6 | IPR013151 | |
| Domain | GCC2_Rab_bind | 2.04e-04 | 7 | 59 | 2 | IPR032023 | |
| Domain | Rab_bind | 2.04e-04 | 7 | 59 | 2 | PF16704 | |
| Domain | Ig_V-set | 4.10e-04 | 199 | 59 | 5 | IPR013106 | |
| Domain | - | 4.34e-04 | 10 | 59 | 2 | 1.10.220.60 | |
| Domain | RWD | 5.30e-04 | 11 | 59 | 2 | SM00591 | |
| Domain | Grip | 5.30e-04 | 11 | 59 | 2 | SM00755 | |
| Domain | RWD | 5.30e-04 | 11 | 59 | 2 | PF05773 | |
| Domain | GRIP | 5.30e-04 | 11 | 59 | 2 | PF01465 | |
| Domain | Ran_BP1 | 6.34e-04 | 12 | 59 | 2 | PF00638 | |
| Domain | GRIP_dom | 6.34e-04 | 12 | 59 | 2 | IPR000237 | |
| Domain | GRIP | 6.34e-04 | 12 | 59 | 2 | PS50913 | |
| Domain | RANBD1 | 6.34e-04 | 12 | 59 | 2 | PS50196 | |
| Domain | RWD-domain | 6.34e-04 | 12 | 59 | 2 | IPR006575 | |
| Domain | RanBD | 7.48e-04 | 13 | 59 | 2 | SM00160 | |
| Domain | Ran_bind_dom | 7.48e-04 | 13 | 59 | 2 | IPR000156 | |
| Domain | Ig-like_dom | 1.00e-03 | 503 | 59 | 7 | IPR007110 | |
| Domain | IG | 2.08e-03 | 421 | 59 | 6 | SM00409 | |
| Domain | Ig_sub | 2.08e-03 | 421 | 59 | 6 | IPR003599 | |
| Domain | TyrKc | 2.72e-03 | 88 | 59 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.72e-03 | 88 | 59 | 3 | IPR020635 | |
| Domain | V-set | 2.72e-03 | 184 | 59 | 4 | PF07686 | |
| Domain | Ig_I-set | 3.05e-03 | 190 | 59 | 4 | IPR013098 | |
| Domain | I-set | 3.05e-03 | 190 | 59 | 4 | PF07679 | |
| Domain | PROTEIN_KINASE_TYR | 3.58e-03 | 97 | 59 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.58e-03 | 97 | 59 | 3 | IPR008266 | |
| Domain | RRM_1 | 4.22e-03 | 208 | 59 | 4 | PF00076 | |
| Domain | IG_LIKE | 4.44e-03 | 491 | 59 | 6 | PS50835 | |
| Domain | RRM | 4.90e-03 | 217 | 59 | 4 | SM00360 | |
| Domain | RRM_dom | 5.74e-03 | 227 | 59 | 4 | IPR000504 | |
| Domain | RRM | 6.01e-03 | 230 | 59 | 4 | PS50102 | |
| Domain | IGc2 | 6.47e-03 | 235 | 59 | 4 | SM00408 | |
| Domain | Ig_sub2 | 6.47e-03 | 235 | 59 | 4 | IPR003598 | |
| Domain | Ig-like_fold | 6.63e-03 | 706 | 59 | 7 | IPR013783 | |
| Domain | LDLR_class-A_CS | 7.08e-03 | 40 | 59 | 2 | IPR023415 | |
| Domain | - | 7.37e-03 | 244 | 59 | 4 | 3.30.70.330 | |
| Domain | Pkinase_Tyr | 7.90e-03 | 129 | 59 | 3 | PF07714 | |
| Domain | TPR | 7.90e-03 | 129 | 59 | 3 | SM00028 | |
| Domain | TPR_repeat | 8.58e-03 | 133 | 59 | 3 | IPR019734 | |
| Domain | Ldl_recept_a | 8.90e-03 | 45 | 59 | 2 | PF00057 | |
| Domain | Nucleotide-bd_a/b_plait | 8.94e-03 | 258 | 59 | 4 | IPR012677 | |
| Domain | - | 9.29e-03 | 46 | 59 | 2 | 4.10.400.10 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.49e-03 | 138 | 59 | 3 | IPR001245 | |
| Domain | LDLRA_1 | 1.01e-02 | 48 | 59 | 2 | PS01209 | |
| Domain | LDLRA_2 | 1.05e-02 | 49 | 59 | 2 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.05e-02 | 49 | 59 | 2 | IPR002172 | |
| Domain | LDLa | 1.05e-02 | 49 | 59 | 2 | SM00192 | |
| Pathway | WP_OVARIAN_INFERTILITY | 3.31e-08 | 35 | 38 | 5 | MM15948 | |
| Pubmed | Analysis of the DAZ gene family in cryptorchidism and idiopathic male infertility. | 9.15e-12 | 4 | 62 | 4 | 15066457 | |
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 7670487 | ||
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 11694340 | ||
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 9321470 | ||
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 19223287 | ||
| Pubmed | Male infertility caused by a de novo partial deletion of the DAZ cluster on the Y chromosome. | 9.15e-12 | 4 | 62 | 4 | 11095434 | |
| Pubmed | Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. | 9.15e-12 | 4 | 62 | 4 | 26232607 | |
| Pubmed | [Microdeletion of chromosome Y in male infertility: role of the DAZ gene]. | 9.15e-12 | 4 | 62 | 4 | 11688365 | |
| Pubmed | 9.15e-12 | 4 | 62 | 4 | 12752250 | ||
| Pubmed | A novel approach for the analysis of DAZ gene copy number in severely idiopathic infertile men. | 9.15e-12 | 4 | 62 | 4 | 11883873 | |
| Pubmed | Four DAZ genes in two clusters found in the AZFc region of the human Y chromosome. | 9.15e-12 | 4 | 62 | 4 | 10936047 | |
| Pubmed | [Study on DAZ gene copy deletion in severe oligozoospermia sperm donor for ICSI]. | 9.15e-12 | 4 | 62 | 4 | 16963411 | |
| Pubmed | Partial DAZ deletions in a family with five infertile brothers. | 9.15e-12 | 4 | 62 | 4 | 12801575 | |
| Pubmed | Targets and dynamics of promoter DNA methylation during early mouse development. | 3.02e-11 | 14 | 62 | 5 | 21057502 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 23579190 | ||
| Pubmed | Kinked β-strands mediate high-affinity recognition of mRNA targets by the germ-cell regulator DAZL. | 4.57e-11 | 5 | 62 | 4 | 22021443 | |
| Pubmed | The mouse Dazla gene encodes a cytoplasmic protein essential for gametogenesis. | 4.57e-11 | 5 | 62 | 4 | 9288969 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 20008336 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 23456578 | ||
| Pubmed | Isolation of a mouse homolog of the human DAZ (Deleted in Azoospermia) gene. | 4.57e-11 | 5 | 62 | 4 | 8679003 | |
| Pubmed | In vivo and in vitro analysis of homodimerisation activity of the mouse Dazl1 protein. | 4.57e-11 | 5 | 62 | 4 | 10903443 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 9143498 | ||
| Pubmed | Bisphenol A exposure modifies DNA methylation of imprint genes in mouse fetal germ cells. | 4.57e-11 | 5 | 62 | 4 | 22699882 | |
| Pubmed | A murine homologue of the human DAZ gene is autosomal and expressed only in male and female gonads. | 4.57e-11 | 5 | 62 | 4 | 8845845 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 11058556 | ||
| Pubmed | AZFc partial deletions in Chilean men with severe spermatogenic failure. | 4.57e-11 | 5 | 62 | 4 | 17416365 | |
| Pubmed | Dazl promotes germ cell differentiation from embryonic stem cells. | 4.57e-11 | 5 | 62 | 4 | 19783541 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 22293198 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 17761180 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 19468308 | ||
| Pubmed | Partial rescue of the Dazl knockout mouse by the human DAZL gene. | 4.57e-11 | 5 | 62 | 4 | 12200456 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 11514340 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 11089564 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 23298641 | ||
| Pubmed | DAZL is essential for stress granule formation implicated in germ cell survival upon heat stress. | 4.57e-11 | 5 | 62 | 4 | 22223682 | |
| Pubmed | A human DAZ transgene confers partial rescue of the mouse Dazl null phenotype. | 4.57e-11 | 5 | 62 | 4 | 10393944 | |
| Pubmed | The human autosomal gene DAZLA: testis specificity and a candidate for male infertility. | 4.57e-11 | 5 | 62 | 4 | 8968756 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 8968755 | ||
| Pubmed | DAZL Regulates Germ Cell Survival through a Network of PolyA-Proximal mRNA Interactions. | 4.57e-11 | 5 | 62 | 4 | 30380414 | |
| Pubmed | Regulated Formation of an Amyloid-like Translational Repressor Governs Gametogenesis. | 4.57e-11 | 5 | 62 | 4 | 26411291 | |
| Pubmed | Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. | 4.57e-11 | 5 | 62 | 4 | 23223451 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 34985827 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 11804965 | ||
| Pubmed | Expression profiling of the developing testis in wild-type and Dazl knockout mice. | 4.57e-11 | 5 | 62 | 4 | 14648873 | |
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 8896558 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 9700189 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 21270429 | ||
| Pubmed | 4.57e-11 | 5 | 62 | 4 | 8661148 | ||
| Pubmed | Expression profiles of the DAZ gene family in human testis with and without spermatogenic failure. | 1.37e-10 | 6 | 62 | 4 | 15066460 | |
| Pubmed | DAZL binds to the transcripts of several Tssk genes in germ cells. | 1.37e-10 | 6 | 62 | 4 | 18452650 | |
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 24086306 | ||
| Pubmed | DAZL binds to 3'UTR of Tex19.1 mRNAs and regulates Tex19.1 expression. | 1.37e-10 | 6 | 62 | 4 | 19247806 | |
| Pubmed | DAZL is a master translational regulator of murine spermatogenesis. | 1.37e-10 | 6 | 62 | 4 | 31355046 | |
| Pubmed | The fate of granulosa cells following premature oocyte loss and the development of ovarian cancers. | 1.37e-10 | 6 | 62 | 4 | 23417416 | |
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 32170089 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 16278232 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 20157580 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 17219433 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 28496037 | ||
| Pubmed | DAZL regulates Tet1 translation in murine embryonic stem cells. | 1.37e-10 | 6 | 62 | 4 | 26077710 | |
| Pubmed | The DAZL family proteins are PABP-binding proteins that regulate translation in germ cells. | 1.37e-10 | 6 | 62 | 4 | 16001084 | |
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 32962040 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 17526644 | ||
| Pubmed | Genetic mapping of a male germ cell-expressed gene Tpx-2 to mouse chromosome 17. | 1.37e-10 | 6 | 62 | 4 | 1869307 | |
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 11390979 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 27632217 | ||
| Pubmed | 1.37e-10 | 6 | 62 | 4 | 1638086 | ||
| Pubmed | Spermatogenesis in testes of Dazl null mice after transplantation of wild-type germ cells. | 1.37e-10 | 6 | 62 | 4 | 14611632 | |
| Pubmed | 3.19e-10 | 7 | 62 | 4 | 10857750 | ||
| Pubmed | 3.19e-10 | 7 | 62 | 4 | 11410654 | ||
| Pubmed | 3.19e-10 | 7 | 62 | 4 | 15081113 | ||
| Pubmed | 3.19e-10 | 7 | 62 | 4 | 22699423 | ||
| Pubmed | 3.19e-10 | 7 | 62 | 4 | 11604102 | ||
| Pubmed | The Dazh gene is expressed in male and female embryonic gonads before germ cell sex differentiation. | 3.19e-10 | 7 | 62 | 4 | 9588208 | |
| Pubmed | DAZL and CPEB1 regulate mRNA translation synergistically during oocyte maturation. | 3.19e-10 | 7 | 62 | 4 | 26826184 | |
| Pubmed | Dazl can bind to dynein motor complex and may play a role in transport of specific mRNAs. | 3.19e-10 | 7 | 62 | 4 | 16946704 | |
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 10951504 | ||
| Pubmed | Mouse dead end1 acts with Nanos2 and Nanos3 to regulate testicular teratoma incidence. | 6.37e-10 | 8 | 62 | 4 | 32339196 | |
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 33749946 | ||
| Pubmed | Hypomethylating therapy in an aggressive stroma-rich model of pancreatic carcinoma. | 6.37e-10 | 8 | 62 | 4 | 23204224 | |
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 29883445 | ||
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 10823932 | ||
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 22621333 | ||
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 32686646 | ||
| Pubmed | 6.37e-10 | 8 | 62 | 4 | 11869379 | ||
| Pubmed | Dazl deficiency leads to embryonic arrest of germ cell development in XY C57BL/6 mice. | 1.15e-09 | 9 | 62 | 4 | 16310179 | |
| Pubmed | 1.15e-09 | 9 | 62 | 4 | 20159962 | ||
| Pubmed | A Gene Regulatory Program for Meiotic Prophase in the Fetal Ovary. | 1.15e-09 | 9 | 62 | 4 | 26378784 | |
| Pubmed | Embryoid bodies from mouse stem cells express oxytocin receptor, Oct-4 and DAZL. | 1.15e-09 | 9 | 62 | 4 | 19695304 | |
| Pubmed | 1.15e-09 | 9 | 62 | 4 | 28235998 | ||
| Pubmed | 1.91e-09 | 10 | 62 | 4 | 10601091 | ||
| Pubmed | 1.91e-09 | 10 | 62 | 4 | 31234534 | ||
| Pubmed | Tesmin transcription is regulated differently during male and female meiosis. | 1.91e-09 | 10 | 62 | 4 | 14648882 | |
| Pubmed | MAX controls meiotic entry in sexually undifferentiated germ cells. | 1.91e-09 | 10 | 62 | 4 | 38433229 | |
| Pubmed | 1.91e-09 | 10 | 62 | 4 | 9922113 | ||
| Pubmed | 1.91e-09 | 10 | 62 | 4 | 23810942 | ||
| Pubmed | 1.91e-09 | 10 | 62 | 4 | 12837688 | ||
| Pubmed | ELAVL2-directed RNA regulatory network drives the formation of quiescent primordial follicles. | 2.50e-09 | 31 | 62 | 5 | 31657143 | |
| Pubmed | 2.96e-09 | 32 | 62 | 5 | 21460039 | ||
| Pubmed | NANOS2 suppresses the cell cycle by repressing mTORC1 activators in embryonic male germ cells. | 2.99e-09 | 11 | 62 | 4 | 34401671 | |
| Cytoband | Yq11.223 | 8.04e-06 | 93 | 62 | 4 | Yq11.223 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q12 | 5.00e-05 | 8 | 62 | 2 | chr9q12 | |
| Cytoband | 12p12 | 1.39e-04 | 13 | 62 | 2 | 12p12 | |
| Cytoband | 15q15.3 | 5.28e-04 | 25 | 62 | 2 | 15q15.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 8.46e-04 | 311 | 62 | 4 | chrYq11 | |
| Cytoband | 10q22.2 | 1.42e-03 | 41 | 62 | 2 | 10q22.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q23 | 3.33e-03 | 220 | 62 | 3 | chr11q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q12 | 5.56e-03 | 82 | 62 | 2 | chr2q12 | |
| GeneFamily | Immunoglobulin like domain containing | 9.11e-05 | 193 | 43 | 5 | 594 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 1.16e-04 | 40 | 43 | 3 | 321 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 5.97e-04 | 163 | 43 | 4 | 590 | |
| GeneFamily | RNA binding motif containing | 1.61e-03 | 213 | 43 | 4 | 725 | |
| GeneFamily | Fibronectin type III domain containing | 6.48e-03 | 160 | 43 | 3 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 6.59e-03 | 161 | 43 | 3 | 593 | |
| Coexpression | TESAR_JAK_TARGETS_MOUSE_ES_D3_DN | 1.13e-08 | 12 | 59 | 4 | MM742 | |
| Coexpression | SASAI_TARGETS_OF_CXCR6_AND_PTCH1_DN | 1.13e-08 | 12 | 59 | 4 | MM781 | |
| Coexpression | WAGSCHAL_EHMT2_TARGETS_UP | 1.99e-07 | 23 | 59 | 4 | MM1293 | |
| Coexpression | MATZUK_SPERMATOGONIA | 6.96e-07 | 31 | 59 | 4 | MM765 | |
| Coexpression | CHEN_ETV5_TARGETS_TESTIS | 9.02e-07 | 33 | 59 | 4 | MM701 | |
| Coexpression | ZHANG_PROLIFERATING_VS_QUIESCENT | 4.55e-06 | 49 | 59 | 4 | M16992 | |
| Coexpression | HUTTMANN_B_CLL_POOR_SURVIVAL_UP | 4.27e-05 | 284 | 59 | 6 | M19993 | |
| Coexpression | MADAN_DPPA4_TARGETS | 4.28e-05 | 86 | 59 | 4 | MM1312 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 5.13e-05 | 32 | 59 | 3 | MM17 | |
| Coexpression | JACKSON_DNMT1_TARGETS_UP | 5.82e-05 | 93 | 59 | 4 | MM1185 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN | 6.17e-05 | 34 | 59 | 3 | M45005 | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_28|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.30e-06 | 173 | 62 | 5 | 66488d01e03264fb193285470901c9c4182fbae8 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.81e-06 | 177 | 62 | 5 | dfaed388926ce050730492a532824af68bf4feff | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.86e-05 | 163 | 62 | 4 | d2fcd6f561748f7d29a051c504f016952ba32d0f | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.04e-05 | 169 | 62 | 4 | 8a6d05b5d60b2b2e43a8ff7521feb79cd6dbd940 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.04e-05 | 169 | 62 | 4 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.25e-05 | 170 | 62 | 4 | 0f215911b5880eeffeb43230f7eeaf55b612eaf2 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.90e-05 | 173 | 62 | 4 | 3877cead288ce9509e6cccf57e55ec5e1bd7ce18 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E-|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 178 | 62 | 4 | 804ac3725c1f88e2212172bfb9aa01d97a735621 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_12|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.10e-04 | 178 | 62 | 4 | 04bfecf5ea5d85c843e48d08718b5d69e7bf834e | |
| ToppCell | 390C-Endothelial_cells-Endothelial-E|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-04 | 178 | 62 | 4 | ad6dc4a375664c919bd48c35c48a561fc5a7de8c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.15e-04 | 180 | 62 | 4 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating-Lymphatic_EC_differentiating_L.2.5.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.18e-04 | 181 | 62 | 4 | e898ecb8d8f2eb2204225b7b0d665cadcd241139 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.20e-04 | 182 | 62 | 4 | 0346f81bbb1f309f3e9d063b20547d548d09472c | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 1.20e-04 | 182 | 62 | 4 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 185 | 62 | 4 | 808d5e880069aff8866cd2c733b9fe568a37701f | |
| ToppCell | severe_influenza-B_intermediate|severe_influenza / disease group, cell group and cell class (v2) | 1.34e-04 | 187 | 62 | 4 | d6db8595aa72fdabc4a056ba6ce09876868a66d5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.34e-04 | 187 | 62 | 4 | 0ef82111b9049cc7ee78d64d240e1f10ab14d6b6 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.34e-04 | 187 | 62 | 4 | dffa8447c2f3fdacf39a7258c6b4e81a25245041 | |
| ToppCell | IPF-Lymphoid-B|Lymphoid / Disease state, Lineage and Cell class | 1.34e-04 | 187 | 62 | 4 | af1327559f7e01bec070881cae52834917c3da65 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 188 | 62 | 4 | 73f6ec915934154f435a376cb274b058ff7c5f35 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_lymph_vessel|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.36e-04 | 188 | 62 | 4 | c2805232618a7b6f844d34e37ad458a9923dbfe1 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.36e-04 | 188 | 62 | 4 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 189 | 62 | 4 | e82211b9dc7540e7a183be2cbcfae39fdf503949 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-04 | 189 | 62 | 4 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 190 | 62 | 4 | a3c6eec6df052105ab78b7e3c78f94218d5912eb | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.42e-04 | 190 | 62 | 4 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC2|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 191 | 62 | 4 | 85dba3a8a52307df52d1d78a6f278501298f3067 | |
| ToppCell | E15.5-Epithelial|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.48e-04 | 192 | 62 | 4 | 3f2ecd428c0c608d7bbd7b403a07399b87761338 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 04f5a2e3dd6beff027b89d66eefdd92036e041af | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | 0aeb5351275c0a91151ea2d52b2cdde172da6731 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.48e-04 | 192 | 62 | 4 | 7197e401e563441ab94815f7619e032ebef9e586 | |
| ToppCell | human_hepatoblastoma-Endothelial_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 1.48e-04 | 192 | 62 | 4 | e09f609fed033a25baacaf4a07bbbae1076da366 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.48e-04 | 192 | 62 | 4 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | 02f633b016ab19bfa65bfd0cf32f000549a62148 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-04 | 193 | 62 | 4 | 5122b1ffba42de190061be34ecdc6176f84e56a3 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-capillary_endothelial_cell_(Cap1)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.51e-04 | 193 | 62 | 4 | ff6e6b825d6c88148216c601580be3c28851ab5c | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.54e-04 | 194 | 62 | 4 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | LPS_only-Endothelial-Endothelial-Activated_Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-04 | 195 | 62 | 4 | 56efeb58df19f357d7d5ce87348d4f196a595421 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.57e-04 | 195 | 62 | 4 | 8f5dfcdaccb0c8318f90a33519a8d6d98ba22943 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 195 | 62 | 4 | 126f46dd15dddcf5701144718bb8ba1ce84b2d1d | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.57e-04 | 195 | 62 | 4 | a432d69b0172211ee4d53675936a1dc9ce1ae1f0 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.60e-04 | 196 | 62 | 4 | 629236f95c838a473b5964a49b7c1b7ad863ea12 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.60e-04 | 196 | 62 | 4 | 6708026bafd19c35c5c4e81911344d36a0f508cd | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.63e-04 | 197 | 62 | 4 | 9b3d6fe76dd7d61a286a28d9466b5f2fece048e1 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 789c97ca9d1e28df3353140046047f11fbccc1d0 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 197 | 62 | 4 | 947042f888335c0829d4d5daeb623973eadb3348 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.66e-04 | 198 | 62 | 4 | 4a70a1ab40fe30b90acd97e4e36067db62acc905 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 198 | 62 | 4 | a75499f8f1630359b64717c300621aa3b1ab44d4 | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-intermediate_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.66e-04 | 198 | 62 | 4 | 75270600b5b29187dfa86f01f8f927ae0621cda4 | |
| ToppCell | medial-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | c5048b31649a0b7eddcd481b0458ed96508f5561 | |
| ToppCell | mLN-Dendritic_cell-cDC1|mLN / Region, Cell class and subclass | 1.69e-04 | 199 | 62 | 4 | 3e25f096ba69fa43ae08adf9ef194ec7ba463fcf | |
| ToppCell | mLN-(5)_Dendritic_cell-(51)_cDC1|mLN / shred on region, Cell_type, and subtype | 1.69e-04 | 199 | 62 | 4 | 041353e2d06241b98845a288f90339f30ea722dd | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | 9021f4be004efd51bb3658e5bbff53589356b3df | |
| ToppCell | distal-2-Endothelial-Capillary_Aerocyte|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | bf70c8bfe932bccac5014e55f82019c5148627e7 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | 84e30c39c2f050aa64af167999824c1cba32ba05 | |
| ToppCell | medial-Endothelial-Capillary_Aerocyte-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.69e-04 | 199 | 62 | 4 | f1039d1ab498fc58f0feba545df05833c235db74 | |
| ToppCell | distal-3-Endothelial-Capillary_Aerocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | e12598a097dd9c4cbf9bb85bfa3057722ef73ad5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 200 | 62 | 4 | 392abf38afc874925618397ae320a630e18b8e0a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-venous_capillary|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 200 | 62 | 4 | ae6cc5462a8a254682793fb8cc348b9721c729bf | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 200 | 62 | 4 | 9e44da8aaac239ed69d674dcd53800c5eaf397cb | |
| ToppCell | Lung_Parenchyma-Control-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 200 | 62 | 4 | 41ac6adbf61763aa8a81a0ed586c4a5542a42cc5 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-04 | 200 | 62 | 4 | fc0fd7b8e16eb593698084dca3f566d4d4bff381 | |
| ToppCell | distal-Endothelial-Capillary_Aerocyte|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | b91f8eb67752a77e1e08e462e50f1b5923695e1b | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.73e-04 | 200 | 62 | 4 | 5109b417c066ecca0252008206b4f4b7a14c8702 | |
| ToppCell | distal-1-Endothelial-Capillary_Aerocyte|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.73e-04 | 200 | 62 | 4 | 59bacd738433cec6d05624a25fdfc087fb3ca3b5 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.73e-04 | 200 | 62 | 4 | 9e5627e11288713aa9b622aae40e849dd6eacd29 | |
| ToppCell | COVID-19-kidney-Epithelial_Doublet|kidney / Disease (COVID-19 only), tissue and cell type | 6.86e-04 | 124 | 62 | 3 | d6f59ddb9b9df02b5201f23fa5fb78f3fd891ee9 | |
| ToppCell | severe_influenza-B_cell|severe_influenza / disease group, cell group and cell class (v2) | 7.52e-04 | 128 | 62 | 3 | 92b250186d6bb08ce4f2f5cc4fb93928f6b92d3a | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell-B_cell_2|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.16e-04 | 137 | 62 | 3 | 2544d1256f11da6e3bad24a871b2253e0ab20d01 | |
| ToppCell | PND07-28-samps-Lymphocyte-B_cell|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.16e-04 | 137 | 62 | 3 | 874e2eaa7846a2832f46b77c726d79f220a4a1cd | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_activate-7|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.35e-04 | 138 | 62 | 3 | 76be06136c83c167cedece7515228ed4d29dd1f0 | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.04e-03 | 143 | 62 | 3 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.06e-03 | 144 | 62 | 3 | 04f9054895be2275eecda687a6eeb02fa5ec69b9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_4|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.14e-03 | 148 | 62 | 3 | 1186ee0d15244fee74c1d09df3967c1b69f8ddce | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 1.19e-03 | 150 | 62 | 3 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Connecting_Tubule_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-03 | 150 | 62 | 3 | 87968ce885a4959616f0321f58517fe8029ba1b1 | |
| ToppCell | Healthy_donor-B_cell|Healthy_donor / disease group, cell group and cell class (v2) | 1.24e-03 | 152 | 62 | 3 | 5768edfde8010324d8594815e73bbfba2c3045f3 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.26e-03 | 153 | 62 | 3 | b25629953ff79aff645845376132b12023067b01 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Goblet_2|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.26e-03 | 153 | 62 | 3 | e9d6b4e895ddb8d6e6c8b043da591ec11365e124 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.33e-03 | 156 | 62 | 3 | ffb9249a115ce31f50b99a7a3d40bf48b9d7f2b0 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.33e-03 | 156 | 62 | 3 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-03 | 157 | 62 | 3 | 4183dbed6b31ebe13ef33eb19ba6d0fb4f625953 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.36e-03 | 157 | 62 | 3 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-03 | 158 | 62 | 3 | 6811dc4f101dfa9a9cc13d949760d43aa522bf3b | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.41e-03 | 159 | 62 | 3 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-03 | 159 | 62 | 3 | d3f81ba22160568ccaa6d2b04ebfd30630f9a6db | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.43e-03 | 160 | 62 | 3 | 94e4f5fc2156dd8163811c3b8b0781ea9b3f2e06 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-03 | 161 | 62 | 3 | fb59d96c2aa9e4654f02bf6ce36bf832776cb4dd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-Degenerative_Endothelial_Cell-Degenerative_endothelial_cell_-_unspecif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-03 | 161 | 62 | 3 | 2a721b6228045adb2dfbcd4990d371f961dc5dc2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.46e-03 | 161 | 62 | 3 | c53c461fc721a7960cef86662f49e2a495520701 | |
| Drug | boron trichloride | 4.90e-10 | 6 | 56 | 4 | CID000025135 | |
| Drug | desmethylazelastine | 5.84e-08 | 16 | 56 | 4 | CID000162558 | |
| Drug | dazmegrel | 1.24e-07 | 19 | 56 | 4 | CID000053555 | |
| Drug | YM 026 | 1.24e-07 | 19 | 56 | 4 | CID000004443 | |
| Drug | AZFd | 2.81e-07 | 23 | 56 | 4 | CID000196489 | |
| Drug | dansylaziridine | 2.81e-07 | 23 | 56 | 4 | CID000104008 | |
| Drug | d-gluconhydroximo-1,5-lactam | 9.83e-07 | 31 | 56 | 4 | CID000003479 | |
| Drug | Vistar | 1.82e-06 | 36 | 56 | 4 | CID000040896 | |
| Drug | 3-bromo-7-nitroindazole | 1.82e-06 | 36 | 56 | 4 | CID000001649 | |
| Drug | molybdenum disulfide | 3.77e-06 | 43 | 56 | 4 | CID000014823 | |
| Drug | 2-chlorodideoxyadenosine | 3.77e-06 | 43 | 56 | 4 | CID000072194 | |
| Drug | propham | 4.14e-06 | 44 | 56 | 4 | CID000024685 | |
| Drug | ridogrel | 8.14e-06 | 52 | 56 | 4 | CID005362391 | |
| Drug | Ornidazole [16773-42-5]; Down 200; 18.2uM; HL60; HG-U133A | 8.56e-06 | 196 | 56 | 6 | 1425_DN | |
| Drug | PHA-00816795 [212631-79-3]; Up 200; 10uM; PC3; HT_HG-U133A | 9.07e-06 | 198 | 56 | 6 | 7076_UP | |
| Drug | azafagomine | 1.18e-05 | 57 | 56 | 4 | CID011957435 | |
| Drug | NSC56408 | 1.65e-05 | 62 | 56 | 4 | CID000005604 | |
| Drug | dibenzoylhydrazine | 1.78e-05 | 3 | 56 | 2 | CID000013085 | |
| Drug | kt S | 2.11e-05 | 66 | 56 | 4 | CID006399216 | |
| Drug | AC1O5U0X | 2.75e-05 | 24 | 56 | 3 | CID006440684 | |
| Drug | azelastine | 3.32e-05 | 74 | 56 | 4 | CID000002267 | |
| Drug | p11-13 | 3.50e-05 | 75 | 56 | 4 | CID000015759 | |
| Drug | BW755C | 8.14e-05 | 93 | 56 | 4 | CID000047795 | |
| Drug | bipy | 9.59e-05 | 97 | 56 | 4 | CID000001474 | |
| Drug | pyridaben | 1.04e-04 | 99 | 56 | 4 | ctd:C428725 | |
| Drug | Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 7014_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.12e-04 | 193 | 56 | 5 | 5566_DN | |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.17e-04 | 195 | 56 | 5 | 4360_DN | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 7011_DN | |
| Drug | Guanfacine hydrochloride [29110-48-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 1279_DN | |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 1.23e-04 | 197 | 56 | 5 | 3708_DN | |
| Drug | SureCN10139725 | 1.24e-04 | 7 | 56 | 2 | CID011765459 | |
| Drug | Piperacillin sodium salt [59703-84-3]; Up 200; 7.4uM; PC3; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 4320_UP | |
| Drug | Avermectin B1 [71751-41-2]; Down 200; 4.8uM; MCF7; HT_HG-U133A | 1.26e-04 | 198 | 56 | 5 | 7218_DN | |
| Drug | Iproniazide phosphate [305-33-9]; Down 200; 14.4uM; HL60; HG-U133A | 1.29e-04 | 199 | 56 | 5 | 1442_DN | |
| Drug | NSC98537 | 1.54e-04 | 473 | 56 | 7 | CID000005410 | |
| Disease | Male sterility due to Y-chromosome deletions | 8.10e-10 | 8 | 56 | 4 | C2931163 | |
| Disease | Partial chromosome Y deletion | 8.10e-10 | 8 | 56 | 4 | C1507149 | |
| Disease | autosomal recessive nonsyndromic deafness 16 (implicated_via_orthology) | 3.54e-06 | 2 | 56 | 2 | DOID:0110471 (implicated_via_orthology) | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 3.56e-06 | 16 | 56 | 3 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 3.56e-06 | 16 | 56 | 3 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 3.56e-06 | 16 | 56 | 3 | cv:C1839071 | |
| Disease | prostate adenocarcinoma (is_marker_for) | 1.58e-04 | 10 | 56 | 2 | DOID:2526 (is_marker_for) | |
| Disease | cholesteryl ester 16:1 measurement | 4.17e-04 | 16 | 56 | 2 | EFO_0010342 | |
| Disease | Uremia | 4.72e-04 | 17 | 56 | 2 | C0041948 | |
| Disease | Hemangiosarcoma | 5.31e-04 | 18 | 56 | 2 | C0018923 | |
| Disease | esophagus adenocarcinoma (is_implicated_in) | 7.26e-04 | 21 | 56 | 2 | DOID:4914 (is_implicated_in) | |
| Disease | Epilepsy, Benign Psychomotor, Childhood | 8.72e-04 | 23 | 56 | 2 | C0393672 | |
| Disease | Epilepsy, Lateral Temporal | 8.72e-04 | 23 | 56 | 2 | C0393682 | |
| Disease | Uncinate Epilepsy | 8.72e-04 | 23 | 56 | 2 | C0014558 | |
| Disease | Epilepsy, Temporal Lobe | 8.72e-04 | 23 | 56 | 2 | C0014556 | |
| Disease | creatinine measurement, chronic kidney disease | 2.02e-03 | 35 | 56 | 2 | EFO_0003884, EFO_0004518 | |
| Disease | colorectal adenocarcinoma (is_implicated_in) | 2.02e-03 | 35 | 56 | 2 | DOID:0050861 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NTLQTYIRCRHPPPG | 361 | P11473 | |
| FLGQTLGPPRTHCPY | 661 | Q6PJG6 | |
| LSQGHLTPLPLYVCP | 446 | P56282 | |
| YPHSPGQVITGCQLL | 171 | Q13117 | |
| YPHSPGQVITGCQLL | 171 | Q9NR90 | |
| HPPLCISTGATVPYF | 371 | Q8N5I2 | |
| AIHPPGPITTATSLY | 796 | Q5JR59 | |
| PRCTSYLNPGLPSHL | 511 | O75747 | |
| LHPSYCQSPRGSPVS | 1156 | Q9P2P5 | |
| HGTCTYILLQSPQLP | 416 | Q6W4X9 | |
| LLESLTCPPYTPTQH | 106 | Q9H0Q0 | |
| NIFHQLGIIPPPSSC | 256 | Q9P2D0 | |
| GHITTTPTPTQFLCP | 86 | P05412 | |
| PNSPYIGSSPTLCHL | 736 | Q5JUK3 | |
| GPLLPTSAPVLLQHY | 236 | Q53F39 | |
| LLLQPVHSPSPTGLC | 496 | O15534 | |
| CYPHPGSELPLQALV | 111 | P18065 | |
| ICTYHLVQSLPTGPT | 276 | A6NMU1 | |
| VYTILSHCDPGPVPI | 421 | Q14005 | |
| CLYAGCIPVTVRPPH | 1066 | Q9P265 | |
| LTCHCGASVIYPPVP | 746 | Q12986 | |
| VAQPPTSYCVAIHLP | 821 | Q2VPB7 | |
| NIPPVTSLPLRCSYH | 91 | Q8N5X7 | |
| VLPHQPLATYTTVGP | 51 | Q16633 | |
| SHHSSYQPLCLPLPV | 506 | A6NKT7 | |
| PDHGYCQPISIPLCT | 111 | Q9UP38 | |
| YSPTCLEPPVLSIHP | 1176 | O75054 | |
| YNHLTTCEPPRPSLG | 281 | Q9Y6J0 | |
| YPHSPGQVITGCQLL | 501 | Q9NQZ3 | |
| HTVELPCTASGYPIP | 241 | Q8TD84 | |
| LHLFPGENCTLTPLP | 396 | Q96RY5 | |
| CPSHTQPLGVYLLTP | 161 | P01880 | |
| CLEPHPYLPVLATSG | 486 | A6NGE4 | |
| YPHSPGQVITGCQLL | 336 | Q86SG3 | |
| EYLCLPAPQISSHSP | 701 | Q14114 | |
| SHHSSYQPLCLPLPV | 506 | Q7Z3J3 | |
| RLSPHGNFLPLCTFP | 11 | O75677 | |
| SPQDGIPYLTHPLCH | 196 | Q8N490 | |
| QCSGVPAPTYHPLET | 16 | Q9NQ03 | |
| GLYATANPVPSQHPC | 81 | Q68DH5 | |
| YLSPLIHVPPGCSTE | 286 | Q8IXI1 | |
| TQYLGHSSPKCLPPT | 441 | Q15572 | |
| PLSHLGPECQPFISS | 471 | Q8IWB4 | |
| ASSVCPQPHYLLPDT | 56 | Q9Y2L1 | |
| LCENHLGPAPPYSIS | 351 | Q7RTU9 | |
| LAPHPLCLSGQLYLP | 91 | Q8NBR9 | |
| PLSHLGPECQPFISS | 471 | Q5VYP0 | |
| HLPVNYPSCLPGISI | 56 | Q9Y3V2 | |
| PGSPNTPLQVHVLCL | 66 | Q6ZRR5 | |
| PPLTLHCNITESYPS | 51 | Q8WVN8 | |
| GCGLAPPHYPTLLTV | 41 | Q8TF68 | |
| PLSHLGPECQPFISS | 471 | Q5VU36 | |
| QLYHCTLLGPASPPA | 621 | P35590 | |
| LIPTLCEYLPPSGHG | 421 | Q9BSI4 | |
| EPHALVQLCGTYPPS | 286 | Q9Y5Y6 | |
| HPAGRYVLCPSTTPS | 861 | P30530 | |
| LQPHLPCSPQYLTHP | 1511 | A7E2V4 | |
| LCENHLGPAPPYSIS | 351 | A6NGW2 | |
| QTLTCTVYAIPPPHH | 441 | P35968 | |
| PEGTPIYLQCNLHAP | 796 | Q6ZQQ6 | |
| LSVHYPPQLLGPSCS | 451 | Q96RL6 | |
| PSYHLRTLLSPVCVP | 101 | Q6ZVH6 | |
| SAQPSLPLYRTCHPI | 1061 | Q70EL1 |